INTRODUCTION: This study examines factors associated with timely follow-up after Pap test in a program providing cervical cancer detection services to medically underserved California women. METHODS: Data between 01 January 1992 and 30 June 2007 were analyzed. Cox proportional hazard regression was used to identify subgroups of women with delayed time to diagnosis or treatment scheduling. The probability of being scheduled for final diagnosis and treatment was assessed using logistic regression analysis. Demographic and clinical characteristics of the women lost to follow up were examined. RESULTS: Time from screening to final diagnosis scheduling differed according to age group, race/ethnicity, and Pap test result. Race/ethnicity and age were associated with whether treatment was scheduled or not. While loss to follow up among those scheduled for final diagnosis was associated with certain patients' characteristics, no such association was found among those who were scheduled for treatment. CONCLUSIONS: Patient's demographic characteristics determine the odds of being scheduled for final diagnosis and treatment as well as timeliness of follow-up from screening to final diagnosis. Findings suggest that the dual goal of reducing health disparities and cost-effective detection and treatment of precancerous disease to prevent cervical cancers cannot be achieved without consideration of racial/ethnic differences and needs.
INTRODUCTION: This study examines factors associated with timely follow-up after Pap test in a program providing cervical cancer detection services to medically underserved California women. METHODS: Data between 01 January 1992 and 30 June 2007 were analyzed. Cox proportional hazard regression was used to identify subgroups of women with delayed time to diagnosis or treatment scheduling. The probability of being scheduled for final diagnosis and treatment was assessed using logistic regression analysis. Demographic and clinical characteristics of the women lost to follow up were examined. RESULTS: Time from screening to final diagnosis scheduling differed according to age group, race/ethnicity, and Pap test result. Race/ethnicity and age were associated with whether treatment was scheduled or not. While loss to follow up among those scheduled for final diagnosis was associated with certain patients' characteristics, no such association was found among those who were scheduled for treatment. CONCLUSIONS:Patient's demographic characteristics determine the odds of being scheduled for final diagnosis and treatment as well as timeliness of follow-up from screening to final diagnosis. Findings suggest that the dual goal of reducing health disparities and cost-effective detection and treatment of precancerous disease to prevent cervical cancers cannot be achieved without consideration of racial/ethnic differences and needs.
Authors: R A Hiatt; R J Pasick; S Stewart; J Bloom; P Davis; P Gardiner; M Johnston; J Luce; K Schorr; W Brunner; F Stroud Journal: Prev Med Date: 2001-09 Impact factor: 4.018
Authors: K Robin Yabroff; Kathleen Shakira Washington; Amy Leader; Elizabeth Neilson; Jeanne Mandelblatt Journal: Med Care Res Rev Date: 2003-09 Impact factor: 3.929
Authors: Jane G Zapka; Elaine Puleo; Stephen H Taplin; Karin Valentine Goins; Marianne Ulcickas Yood; Judy Mouchawar; Carol Somkin; M Michele Manos Journal: Prev Med Date: 2004-07 Impact factor: 4.018
Authors: Christopher S Lathan; Angel Cronin; Reginald Tucker-Seeley; S Yousuf Zafar; John Z Ayanian; Deborah Schrag Journal: J Clin Oncol Date: 2016-02-29 Impact factor: 44.544
Authors: Vicki B Benard; William Howe; Janet Royalty; William Helsel; William Kammerer; Lisa C Richardson Journal: J Womens Health (Larchmt) Date: 2012-04-16 Impact factor: 2.681
Authors: Ambili Ramachandran; Karen M Freund; Sharon M Bak; Timothy C Heeren; Clara A Chen; Tracy A Battaglia Journal: J Womens Health (Larchmt) Date: 2014-12-16 Impact factor: 2.681
Authors: Rachel L Winer; Jasmin A Tiro; Diana L Miglioretti; Chris Thayer; Tara Beatty; John Lin; Hongyuan Gao; Kilian Kimbel; Diana S M Buist Journal: Contemp Clin Trials Date: 2017-11-04 Impact factor: 2.226
Authors: Chyke A Doubeni; Nicole B Gabler; Cosette M Wheeler; Anne Marie McCarthy; Philip E Castle; Ethan A Halm; Mitchell D Schnall; Celette S Skinner; Anna N A Tosteson; Donald L Weaver; Anil Vachani; Shivan J Mehta; Katharine A Rendle; Stacey A Fedewa; Douglas A Corley; Katrina Armstrong Journal: CA Cancer J Clin Date: 2018-03-30 Impact factor: 508.702